{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:33:58Z","timestamp":1793795638087,"version":"4.6.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,22]]},"DOI":"10.1093\/ehjcvp\/pvag037","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T11:37:03Z","timestamp":1779622623000},"page":"437-443","source":"Crossref","is-referenced-by-count":2,"title":["When randomization is not enough: divergent \u03b2-blocker trials and the illusion of universal causality"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3875-8621","authenticated-orcid":false,"given":"Elmir","family":"Omerovic","sequence":"first","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , 41345 Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , 41345 Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9483-5962","authenticated-orcid":false,"given":"Truls","family":"R\u00e5munddal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , 41345 Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , 41345 Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Jha","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , 41345 Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , 41345 Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petur","family":"Petursson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , 41345 Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , 41345 Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9095-1218","authenticated-orcid":false,"given":"Kristofer","family":"Skoglund","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , 41345 Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , 41345 Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araz","family":"Rawshani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , 41345 Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , 41345 Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Redfors","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , 41345 Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , 41345 Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2026092119571037200_pvag037-B1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa2504735","article-title":"Treatment with Beta-blockers after myocardial infarction without reduced ejection fraction (REBOOT)","volume":"393","author":"Ibanez","year":"2025","journal-title":"N Engl J Med"},{"key":"2026092119571037200_pvag037-B2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa2505985","article-title":"Beta-blockers after myocardial infarction in patients without reduced ejection fraction: BETAMI-DANBLOCK","volume":"393","author":"Munkhaugen","year":"2025","journal-title":"N Engl J Med"},{"key":"2026092119571037200_pvag037-B3","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0140-6736(25)01592-2","article-title":"\u03b2-Blocker therapy after myocardial infarction with mildly reduced ejection fraction: individual patient data meta-analysis","volume":"406","author":"Rossello","year":"2025","journal-title":"Lancet"},{"key":"2026092119571037200_pvag037-B4","volume-title":"Nature's Capacities and Their Measurement","author":"Cartwright","year":"1989"},{"key":"2026092119571037200_pvag037-B5","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:osobl\/9780199841608.001.0001","volume-title":"Evidence-Based Policy: A Practical Guide to Doing It Better","author":"Cartwright","year":"2012"},{"key":"2026092119571037200_pvag037-B6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/eurheartj\/ehaf673","article-title":"Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial","volume":"47","author":"Rossello","year":"2026","journal-title":"Eur Heart J"},{"key":"2026092119571037200_pvag037-B7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1214\/14-STS486","article-title":"External validity: from do-Calculus to transportability across populations","volume":"29","author":"Pearl","year":"2014","journal-title":"Stat Sci"},{"key":"2026092119571037200_pvag037-B8","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1056\/NEJM198212163072505","article-title":"Oxidation phenotype\u2014a significant determinant of metoprolol metabolism and response","volume":"307","author":"Lennard","year":"1982","journal-title":"N Engl J Med"},{"key":"2026092119571037200_pvag037-B9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.fpc.0000239974.69464.f2","article-title":"CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure","volume":"17","author":"Sistonen","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"2026092119571037200_pvag037-B10","doi-asserted-by":"crossref","first-page":"11825","DOI":"10.1073\/pnas.90.24.11825","article-title":"Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine","volume":"90","author":"Johansson","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026092119571037200_pvag037-B11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/HJR.0b013e328334f42d","article-title":"Cardiac rehabilitation in Europe: results from the European cardiac rehabilitation inventory survey","volume":"17","author":"Bjarnason-Wehrens","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2026092119571037200_pvag037-B12","first-page":"255","article-title":"Cardiac rehabilitation availability and delivery in Europe: how does it differ by region?","volume":"5","author":"Abreu","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026092119571037200_pvag037-B13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2026092119571037200_pvag037-B14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMoa2512686","article-title":"Beta-blocker trialists\u2019 collaboration. Beta-blockers after myocardial infarction with normal ejection fraction","volume":"394","author":"Kristensen","year":"2025","journal-title":"N Engl J Med"},{"key":"2026092119571037200_pvag037-B15","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","article-title":"Beta-blockers after myocardial infarction and preserved ejection fraction","volume":"390","author":"Yndigegn","year":"2024","journal-title":"N Engl J Med"},{"key":"2026092119571037200_pvag037-B16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199347","article-title":"Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"13","author":"Watanabe","year":"2018","journal-title":"PLoS One"},{"key":"2026092119571037200_pvag037-B17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence\u2014imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2026092119571037200_pvag037-B18","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence\u2014inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2026092119571037200_pvag037-B19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"2026092119571037200_pvag037-B20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jclinepi.2022.07.015","article-title":"GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions","volume":"150","author":"Sch\u00fcnemann","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"2026092119571037200_pvag037-B21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ahj.2022.05.017","article-title":"Rationale and design of SWITCH-SWEDEHEART: a registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute coronary syndrome","volume":"251","author":"Omerovic","year":"2022","journal-title":"Am Heart J"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag037\/68439476\/pvag037.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/6\/437\/68439476\/pvag037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/6\/437\/68439476\/pvag037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:57:22Z","timestamp":1790035042000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/12\/6\/437\/8698915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvag037","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,6,1]]}}}